Breaking News Instant updates and real-time market news.

MOS

Mosaic

$26.32

-0.475 (-1.77%)

, COF

Capital One

$97.93

-1.32 (-1.33%)

04:55
03/01/18
03/01
04:55
03/01/18
04:55

Structured Finance Industry Group to hold a conference

SFIG Vegas Conference 2018 will be held in Las Vegas on February 25-28.

MOS

Mosaic

$26.32

-0.475 (-1.77%)

COF

Capital One

$97.93

-1.32 (-1.33%)

MCO

Moody's

$166.88

-1.49 (-0.88%)

LC

LendingClub

$3.15

-0.05 (-1.56%)

MET

MetLife

$46.19

-1.03 (-2.18%)

DPZ

Domino's Pizza

$222.41

-4.06 (-1.79%)

FNMA

Fannie Mae

$1.65

-0.05 (-2.94%)

JEF

Jefferies Financial Group

$0.00

(0.00%)

BLK

BlackRock

$549.43

-3.34 (-0.60%)

BAC

Bank of America

$31.98

-0.23 (-0.71%)

ALLY

Ally Financial

$27.90

0.01 (0.04%)

WFC

Wells Fargo

$58.41

-0.8 (-1.35%)

C

Citi

$75.49

-0.89 (-1.17%)

GS

Goldman Sachs

$262.93

-4.25 (-1.59%)

JPM

JPMorgan

$115.50

-1.86 (-1.58%)

MS

Morgan Stanley

$56.02

-0.7 (-1.23%)

CS

Credit Suisse

$18.36

-0.38 (-2.03%)

DB

Deutsche Bank

$15.94

-0.46 (-2.80%)

IBM

IBM

$155.83

-0.72 (-0.46%)

F

Ford

$10.61

(0.00%)

STT

State Street

$106.15

-1.02 (-0.95%)

PMT

PennyMac Mortgage

$16.67

-0.41 (-2.40%)

FMCC

Freddie Mac

$1.60

-0.05 (-3.03%)

SLM

Sallie Mae

$10.91

-0.07 (-0.64%)

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 15

    Mar

  • 15

    Mar

  • 19

    Mar

  • 22

    Mar

  • 13

    Apr

  • 08

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jul

  • 12

    Oct

MOS Mosaic
$26.32

-0.475 (-1.77%)

02/21/18
JPMS
02/21/18
UPGRADE
JPMS
Overweight
Mosaic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Mosaic to Overweight.
02/11/18
CIBC
02/11/18
UPGRADE
CIBC
Neutral
Mosaic upgraded to Neutral from Underperformer at CIBC
02/21/18
JPMS
02/21/18
UPGRADE
Target $30
JPMS
Overweight
JPMorgan upgrades Mosaic to Overweight on favorable phosphate pricing
JPMorgan analyst Jeffrey Zekauskas upgraded Mosaic to Overweight from Neutral and raised his price target for the shares to $30 from $26. The company's reduced phosphate production in the U.S. has created a positive price dynamic, Zekauskas tells investors in a research note. The analyst expects Mosaic's free cash flow generation to increase from 3.6% for 2018 to 6.1% of its share price for 2019. Zekauskas adds that if the China export pattern were to continue, annual production from China could decrease as much as 3M tons, which would tighten the 65M ton phosphate market.
02/21/18
02/21/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the company's reduced phosphate production in the U.S. has created a positive price dynamic. 2. BT Group (BT) upgraded to Hold from Sell at Deutsche Bank analyst Robert Grindle saying the stock has fallen 16% in 2018. 3. Palo Alto Networks (PANW) upgraded to Positive from Neutral at Susquehanna with analyst Anne Meisner citing expectations for a return to stable revenue growth, positive industry feedback on the company, encouraging channel checks, and relative valuation. 4. Gentherm (THRM) upgraded to Buy from Hold at Craig-Hallum with analyst Steve Dyer saying the new CEO brings renewed focus on growth, margin expansion and he expects stock to re-rate as a result. 5. Finish Line (FINL) upgraded to Neutral from Underperform at Buckingham with analyst Scott Krasik saying shares are down 40% year-to-date, with no change to fundamentals, and does not see a catalyst to move shares materially lower over the next 6-12 months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COF Capital One
$97.93

-1.32 (-1.33%)

01/24/18
BMOC
01/24/18
NO CHANGE
Target $140
BMOC
Outperform
Capital One price target raised to $140 from $134 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Capital One (COF) to $140, saying the company's "growth math" on earnings can transition from a headwind to a tailwind this year on benefits of the U.S. tax reform and Cabela's (CAB) loans acquisition. The analyst maintains that he is bullish on banks this year, and Capital One is his "highest conviction investment recommendation". Fotheringham keeps his Outperform rating on the stock.
01/24/18
WELS
01/24/18
NO CHANGE
Target $117
WELS
Outperform
Capital One price target raised to $117 from $112 at Wells Fargo
Wells Fargo analyst Donald Fandetti raised his price target for Capital One to $117 from $112 following quarterly results. The analyst reiterates an Outperform rating on the shares.
02/21/18
NOMU
02/21/18
DOWNGRADE
Target $109
NOMU
Neutral
Capital One downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Bill Carcache downgraded Capital One Financial to Neutral and lowered his price target for the shares to $109 from $111. The analyst believes the benefit of improving credit is now fully discounted in the shares and he sees "little room" for positive earnings revisions given the company's slowing sales growth.
02/21/18
02/21/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Capital One (COF) downgraded to Neutral from Buy at Nomura Instinet with analyst Bill Carcache saying he believes the benefit of improving credit is now fully discounted in the shares and he sees "little room" for positive earnings revisions given the company's slowing sales growth. 2. Lionsgate (LGF.A, LGF.B) downgraded to Market Perform from Outperform at Bernstein with analyst Todd Juenger saying he believes competitive investment from rival premium and SVOD services has gotten much more intense, and notes that increased programming investment at Starz is a necessary but recurring cost of doing business, which means the normalized growth rate for Starz has to be lower. 3. Match Group (MTCH) downgraded to Neutral from Overweight at JPMorgan with analyst Doug Anmuth saying he sees fewer catalysts in the first half of 2018 now that the surge in Tinder Gold has passed. 4. BHP Billiton (BHP) downgraded to Neutral from Buy at Citi with analyst Heath Jansen saying the company's first half of fiscal 2018 results were below expectations. 5. Regeneron (REGN) downgraded to Hold from Buy at Canaccord with analyst John Newman citing concern over the company's decision to not provide guidance for Eylea, which is concerning because it will remain the company's core revenue component for many years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MCO Moody's
$166.88

-1.49 (-0.88%)

02/12/18
FBCO
02/12/18
NO CHANGE
Target $187
FBCO
Neutral
Moody's price target raised to $187 from $161 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for Moody's to $187 from $161 after a "strong" update as expected, with margins looking a bit conservative. The analyst reiterates a Neutral rating on the shares.
01/11/18
NOMU
01/11/18
INITIATION
Target $180
NOMU
Buy
Moody's initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Dan Dolev started Moody's (MCO) with a Buy rating and $180 price target. The analyst prefers the stock over S&P Global (SPGI) citing its "superior execution" in ratings and opportunities to improve growth and margin in analytics.
02/12/18
WELS
02/12/18
NO CHANGE
Target $160
WELS
Market Perform
Moody's price target raised to $160 from $148 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for Moody's to $160 from $148 after the company reported Q4 revenue and EPS ahead of expectations, with upside driven primarily by strong issuance across all 4 divisions. The analyst reiterates a Market Perform rating on the shares.
02/14/18
ARGS
02/14/18
NO CHANGE
Target $190
ARGS
Buy
Moody's price target raised to $190 from $165 at Argus
Argus analyst John Eade raised his price target on Moody's to $190 and kept his Buy rating after a Q4 earnings beat, with results benefiting from the recent acquisition of Bureau van Dijk. The analyst is positive on the company's position to benefit from the "secular trends of global GDP growth and debt market disintermediation", along with opportunities to develop new products, raise margins, and grow through targeted acquisitions. Eade believes the valuation on Moody's is attractive relative to peers, with expected FY18 PE of 20.6-times vs. group range of 18-29-times.
LC LendingClub
$3.15

-0.05 (-1.56%)

02/23/18
02/23/18
DOWNGRADE
Target $4

Neutral
LendingClub downgraded to Neutral on competitive concerns at Guggenheim
As previously reported, Guggenheim downgraded LendingClub to Neutral from Buy and maintained a $4 price target. Analyst Jeff Cantwell expects significant headwinds to top line growth and margin expansion due to an intensifying competitive environment in LendingClub's core consumer lending business, especially from balance sheet lenders. Further, the analyst said future legal expenses are not currently quantifiable and could serve as another headwind.
02/23/18
GUGG
02/23/18
DOWNGRADE
GUGG
Neutral
LendingClub downgraded to Neutral from Buy at Guggenheim
12/11/17
MAXM
12/11/17
NO CHANGE
Target $6
MAXM
Buy
LendingClub price target lowered to $6 from $8 at Maxim
Maxim analyst Michael Diana lowered his price target on LendingClub to $6 from $8, citing the company's below-consensus FY18 EBITDA guidance of $75M-90M at its first investor day last week. Diana keeps his Buy rating on LendingClub thanks to longer-term positives, including increasing penetration of unsecured personal loan market for credit card debt refinancing, rising "predictability" of the company's credit algorithms, and the "virtuous cycle" of predictable credit leading to lower rates for borrowers. The analyst says that 2019, rather than 2018, will now likely be the year highlighted by rising revenue from new products and operating efficiency.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
MET MetLife
$46.19

-1.03 (-2.18%)

01/19/18
SBSH
01/19/18
NO CHANGE
Target $63
SBSH
Buy
Citi removes Voya Financial, adds Prudential to Focus List
Citi analyst Suneet Kamath removed Voya Financial (VOYA) from his firm's Focus List saying the sale of its Annuity operation, a significant positive catalyst, is largely reflected in the valuation. The analyst keeps a Buy rating on the shares with a $63 price target. Kamath added Prudential (PRU) to the Focus List and keeps a Buy rating on the shares with a $130 price target. He believes the company could replace MetLife (MET) as the "default, large-cap life insurer in the space for investors to own." The analyst keeps a Sell rating on MetLife with a $48 price target.
01/31/18
GSCO
01/31/18
DOWNGRADE
Target $57
GSCO
Buy
MetLife downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman analyst Alex Scott removed MetLife from the Conviction Buy List due to ongoing uncertainty from an expanded reserve review following the announcement it will incur a $525M-$575M charge. The analyst said there is potential for further reserve action resulting in earnings risk driven by lower potential capital deployment due to the risk of MetLife halting share repurchases. Scott maintains a Buy rating on MetLife and a $57 price target on shares.
01/31/18
01/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Market Perform from Outperform at BMO Capital with analyst Tim Long saying that while the press has recently speculated about the order cuts for iPhone X, which he says reflects his first quarter model for a "weaker mix," he is "more concerned by a secular change" for the iPhone product. AK Steel (AKS) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners saying AK Steel's "disappointing" first quarter and normalized earnings guidance is due to management's "commodity neutral approach," which limits benefits from higher steel prices. 3. U.S. Bancorp (USB) downgraded to Underweight from Neutral at JPMorgan with analyst Vivek Juneja saying the benefit from tax cuts and improving consumer spending are likely to be offset by increased tech spending. 4. Wayfair (W) downgraded to Accumulate from Buy at Gordon Haskett analyst Chuck Grom saying he believes it is important to remain disciplined with the stock at an all-time high, though Grom notes the rating change should not be interpreted as a concern for near-term sales trends, which he believes appear strong. 5. MetLife (MET) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Alex Scott citing ongoing uncertainty from an expanded reserve review following the announcement it will incur a $525M-$575M charge. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/02/18
DBAB
01/02/18
INITIATION
Target $55
DBAB
Hold
MetLife initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Joshua Shanker started MetLife with a Hold rating and $55 price target. The analyst sees limited share upside until the company can generate a consistency of earnings growth.
DPZ Domino's Pizza
$222.41

-4.06 (-1.79%)

02/21/18
FBCO
02/21/18
NO CHANGE
Target $245
FBCO
Outperform
Domino's Pizza price target raised to $245 from $235 at Credit Suisse
Credit Suisse analyst Jason West raised his price target for Domino's Pizza (DPZ) to $245 from $235 following quarterly results. Commenting on a report by the Brazil Journal regarding a potential acquisition by Restaurant Brands (QSR), West says he continues to believe that a merger is unlikely. The analyst reiterates an Outperform rating on Domino's Pizza shares.
02/21/18
OPCO
02/21/18
NO CHANGE
Target $240
OPCO
Outperform
Domino's Pizza price target raised to $240 from $230 at Oppenheimer
Oppenheimer analyst Brian Bittner raised his price target for Domino's Pizza to $240 from $230 after the company delivered a "solid" quarter. The analyst believes his Domino's Pizza thesis remains intact highlighted by fundamentals that are unmatched by restaurant peers. He reiterates an Outperform rating on the shares.
02/27/18
OPCO
02/27/18
NO CHANGE
Target $75
OPCO
Outperform
Papa John's a more logical target for Restaurant Brands, says Oppenheimer
Oppenheimer analyst Brian Bittner says that while Domino's Pizza (DPZ) has been the center of speculation, his analysis suggests Papa John's (PZZA) represents the most logical target for Restaurant Brands (QSR). The analyst points out that Domino's Pizza larger size and valuation would require a major equity raise whereas Papa John's could be fully-funded internally by cash and pro-forma leverage. Domino's Pizza fundamentals are best-in-class, but Papa John's anatomy better fits Restaurant Brands' deal characteristics, he contends. Bittner reiterates an Outperform rating and $75 price target on Restaurant Brands' shares.
02/21/18
BERN
02/21/18
NO CHANGE
Target $230
BERN
Market Perform
Domino's Pizza price target raised to $230 from $200 at Bernstein
Bernstein analyst Sara Senatore raised her price target for Domino's Pizza to $230 from $200 while reiterating a Market Perform rating on the shares as she believes tax and cash return support EPS, but long-term comp guidance no longer looks overly conservative.
FNMA Fannie Mae
$1.65

-0.05 (-2.94%)

06/15/17
WEDB
06/15/17
UPGRADE
WEDB
Outperform
Beazer Homes upgraded on loosening credit standards at Wedbush
As noted earlier, Wedbush upgraded Beazer Homes (BZH) to Outperform from Neutral. Analyst Jay McCanless upgraded the stock based on what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." The analyst says that Beazer focuses on "entry level consumers who..benefit most from lower lending standards." Target remains $15.
12/22/17
KBWI
12/22/17
NO CHANGE
KBWI
Keefe Bruyette keeps $1 price targets on Fannie and Freddie
The Federal Housing Finance Agency, as conservator of Fannie Mae (FNMA) and Freddie Mac (FMCC), and the Department of the Treasury agreed to reinstate a $3B capital reserve amount under the Senior Preferred Stock Purchase Agreements for each of the companies beginning in Q4, Keefe Bruyette analyst Bose George told investors last night in a research note. The government-sponsored enterprises are still expected to incur deferred tax asset write-downs if the corporate tax rate falls to 21% from the current 35%, George points out. He estimates that the write-down will be $12B for Fannie Mae and $7B for Freddie Mac. The analyst does not see the reinstatement of the capital buffer as a change in policy towards the GSEs. As such, George makes no changes to his outlook on the shares and keeps Underperform ratings on both Fannie and Freddie with $1 price targets. Fannie is down 2% to $2.78 while Freddie is down 3% to $2.60 in morning trading.
JEF Jefferies Financial Group
$0.00

(0.00%)

BLK BlackRock
$549.43

-3.34 (-0.60%)

01/25/18
01/25/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Discover (DFS) downgraded to In Line from Outperform at Evercore ISI. 2. BlackRock (BLK) downgraded to Neutral from Buy at Citi with analyst William Katz saying the "revaluation thesis" is now well understood. 3. bluebird bio (BLUE) downgraded to Market Perform from Outperform at Leerink with analyst Michael Schmidt saying the company's clinical stage pipeline now is fairly valued while visibility into additional near-term sources of upside is limited. 4. Jagged Peak Energy (JAG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Scott Hanold citing a tight frac service market in the Permian that lowers his projected growth outlook, saying the company is "more susceptible to frac service constraints due to its smaller scale and being a relatively newer entrant." 5. Varian Medical (VAR) downgraded to Sell from Neutral at Goldman Sachs with analyst Isaac Ro saying shares offer poor risk/reward versus MedTech peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/18
SBSH
01/25/18
DOWNGRADE
Target $625
SBSH
Neutral
BlackRock downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded BlackRock to Neutral saying the "revaluation thesis" is now well understood . The analyst sees less positive earnings and valuation surprise potential at current stock levels. He keeps a $625 price target for BlackRock shares.
01/16/18
ARGS
01/16/18
NO CHANGE
Target $620
ARGS
Buy
BlackRock price target raised to $620 from $520 at Argus
Argus analyst Stephen Biggar raised his price target on BlackRock to $620, citing the company's Q4 earnings beat and higher than expected Q4 inflows. The analyst also notes BlackRock's anticipated effective tax rate in 2018 reduced to 23% from 29% in 2017 and higher asset levels to begin the new year. Biggar keeps his Buy rating on BlackRock, adding that the stock should trade at a premium valuation relative to peers based on its "above-average operating margins, stable long-term asset inflows, and a history of product innovation".
01/16/18
ARGS
01/16/18
NO CHANGE
Target $170
ARGS
Buy
PNC Financial price target raised to $170 from $150 at Argus
Argus analyst Stephen Biggar raised his price target on PNC Financial (PNC) to $170, citing the company's Q4 earnings beat that also featured a 9% rise in net interest income, a 5% increase in average loans, and a 19bps net interest margin expansion. The analyst also notes PNC Financial's management forecasting a 2018 effective tax rate of 17%, down from 25% paid in 2017. Biggar keeps his Buy rating on PNC Financial, adding that the stock should trade at a premium to peers based on its 21% stake in BlackRock (BLK) which offers a "healthy" recurring dividend stream.
BAC Bank of America
$31.98

-0.23 (-0.71%)

01/18/18
BMOC
01/18/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America price target raised to $34 from $31 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Bank of America to $34 despite its "expense-driven" miss on Q4 earnings. Fotheringham says he remains bullish on banks based on the "indirect benefits of tax reform", while keeping his Market Perform rating on Bank of America given its two-year forward PE valuation trading around long-term historical average.
01/18/18
RBCM
01/18/18
NO CHANGE
Target $35
RBCM
Outperform
Bank of America price target raised to $35 from $30 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Bank of America to $35, citing a "strong all around performance" in Q4 along with the bank's commitment to keeping a low expense and growing top line profile. Cassidy says the bank remains "rate sensitive" and expects some $3.3B in net interest income from a 100bps move in short term rates. The analyst also keeps his Outperform rating on Bank of America, pointing to a positive impact from a stronger U.S. economy on its businesses, along with the return of excess capital, supporting a higher stock price view.
01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
ALLY Ally Financial
$27.90

0.01 (0.04%)

01/31/18
BMOC
01/31/18
DOWNGRADE
Target $52
BMOC
Market Perform
Ally Financial downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst James Fotheringham downgraded Ally Financial to Market Perform "exclusively" on valuation and maintained a $52 price target on shares.
01/12/18
JPMS
01/12/18
DOWNGRADE
Target $31
JPMS
Neutral
Ally Financial downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Shane downgraded Ally Financial to Neutral and lowered his price target for the shares to $31 from $32. The analyst says the stock's discount to tangible book value is no longer as compelling.
01/08/18
OPCO
01/08/18
INITIATION
Target $38
OPCO
Outperform
Ally Financial initiated with an Outperform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Ally Financial with an Outperform rating and a price target of $38. Chittenden says that despite the challenging backdrop for auto industry loan growth, the company persists with its efforts of diversifying its business by "removing high-cost funding and ramping up deposit funding". The analyst also anticipates continued improvement in Ally's non-insurance and insurance efficiency ratios.
01/31/18
WELS
01/31/18
NO CHANGE
Target $35
WELS
Outperform
Ally Financial price target raised to $35 from $30 at Wells Fargo
Wells Fargo analyst Donald Fandetti raised his price target for Ally Financial to $35 from $30 following quarterly results. The analyst reiterates an Outperform rating on the shares.
WFC Wells Fargo
$58.41

-0.8 (-1.35%)

02/05/18
RBCM
02/05/18
DOWNGRADE
RBCM
Underperform
Wells Fargo downgraded to Underperform at RBC Capital after Fed action
As reported earlier, RBC Capital analyst Gerard Cassidy downgraded Wells Fargo two notches to Underperform from Outperform and cut his price target to $50 from $65. Cassidy cites the latest regulatory action against the bank by the Fed which prohibits its balance sheet from growing. The analyst notes that he was surprised by the Fed's Cease and Desist Order given the investment made by the bank to remedy its sales practices issues.
02/21/18
MSCO
02/21/18
NO CHANGE
Target $136
MSCO
Overweight
Morgan Stanley sees JPMorgan turning tax savings into market share gains
Morgan Stanley analyst Betsy Graseck raised her 2022 EPS estimate for JPMorgan (JPM) by 2%, or 34c, stating that she expects the bank to reach top 5 in the 15-20 new markets it previously said it will use a part of its tax savings reinvestments to enter. The 34c in EPS she estimates JPMorgan can add by building out its presence in 20 new markets by 2022 is "far more compelling" than using the same amount of money to buy back stock, which would increase 2022 EPS only 5c, said Graseck. The analyst sees about a third of JPMorgan's new deposit share gains to come from Wells Fargo (WFC) and cut her 2022 EPS forecast for the latter by 1.2%. Graseck keeps an Overweight rating on JPMorgan ahead of the bank's February 27 investor day and increased her price target on the stock to $136 from $133.
02/05/18
UBSW
02/05/18
NO CHANGE
Target $63
UBSW
Neutral
Wells Fargo consent order a material setback, says UBS
UBS analyst Saul Martinez views Wells Fargo's consent order as a material setback, as the company will be unable to grow its assets until the Fed approves plans to improve board oversight and governance and overall compliance and operational risk management. Martinez maintained his Neutral rating and $63 price target on Wells Fargo shares.
02/05/18
02/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Market Perform from Outperform at Keefe Bruyette, to Neutral from Buy at Citi, to Underperform from Outperform at RBC Capital, to Underweight from Neutral at JPMorgan, and two notches to Underweight from Overweight at Morgan Stanley. 2. Dick's Sporting (DKS) downgraded to Underweight from Equal Weight at Barclays with analyst Matthew McClintock saying sentiment on the shares have improved over the past month under the narrative that Dick's could become the next Best Buy (BBY). 3. Amgen (AMGN) downgraded to Neutral from Overweight at Atlantic Equities with analyst Steve Chesney citing relative valuation and more balanced risk/reward on Repatha's commercial trajectory and the of legacy biologics given biosimilar, branded and IP risks. 4. Marathon Petroleum (MPC) and MPLX (MPLX) were downgraded to Hold from Buy at Jefferies. 5. VMware (VMW) downgraded to Neutral from Buy at Citi with analyst Walter Pritchard saying he sees "no easy deal" for Dell and expects the overhang to cap VMware shares around the $138 level. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$75.49

-0.89 (-1.17%)

01/17/18
VERF
01/17/18
DOWNGRADE
VERF
Hold
Citi downgraded to Hold from Buy at Vertical Group
01/17/18
01/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Longbow with analyst Shawn Harrison saying the current iPhone cycle is "good, not great." 2. Dish (DISH) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benjamin Swinburne saying he now sees fewer likely buyers of its assets than hoped. 3. Juniper (JNPR) downgraded to Underweight from Equal Weight at Barclays with analyst Mark Moskowitz citing a lack of service provider rebound in 2018 as well as a rising threat from Arista in routing. 4. Citi (C) was downgraded to Hold from Buy at Vertical Group and to Market Perform from Outperform at Keefe Bruyette. 5. Shell Midstream (SHLX) downgraded to Hold from Buy at Stifel with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
RBCM
01/17/18
NO CHANGE
Target $85
RBCM
Outperform
Citi price target raised to $85 from $79 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Citi to $85 and kept his Outperform rating following Q4 earnings. Cassidy says that non-cash charges from tax reform masked the quarter's performance, with underlying trends for Citi remaining strong. The analyst adds that CitiGroup importantly reiterated the $60B capital return goal through CCAR despite the regulatory capital hit from the tax legislation.
GS Goldman Sachs
$262.93

-4.25 (-1.59%)

01/18/18
RBCM
01/18/18
NO CHANGE
Target $265
RBCM
Sector Perform
Goldman Sachs price target raised to $265 from $240 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Goldman Sachs to $265 and kept his Sector Perform rating following Q4 earnings. Cassidy contends that the weak trading results, particularly in FICC, were more than offset by Goldman's "diversified revenue mix, led by strong Investment banking results and private equity gains". The analyst also notes the company's efforts to grow and deepen relationships across its major businesses, while deriving further benefits from the "actual and perceived loosening of regulations under the Trump administration".
01/25/18
WELS
01/25/18
NO CHANGE
Target $320
WELS
Outperform
Goldman Sachs price target raised to $320 from $295 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Goldman Sachs to $320 form $295 saying it should have the highest pre-tax margin this decade by 2019. The analyst notes that Goldman has preserved more of its infrastructure than peer even while reducing comp and non-comp expense, which should result in greater revenues at lower marginal cost. Mayo reiterates an Outperform rating on the shares.
JPM JPMorgan
$115.50

-1.86 (-1.58%)

02/13/18
KBWI
02/13/18
UPGRADE
Target $127
KBWI
Outperform
JPMorgan upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded JPMorgan to Outperform with an unchanged price target of $127. The analyst views the recent pullback in the shares as a buying opportunity.
02/21/18
JEFF
02/21/18
NO CHANGE
JEFF
JPMorgan price target raised to $131 from $124 at Jefferies
Jefferies analyst Ken Usdin raised his price target on JPMorgan to $131 from $124, as well his FY18/FY19 EPS estimates for the company, ahead of JPMorgan's Investor Day on February 27, where Usdin expects to hear an "upbeat message about the macro backdrop, organic growth, and ongoing investments." Usdin maintained a Buy rating on JPMorgan shares.
02/13/18
02/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MS Morgan Stanley
$56.02

-0.7 (-1.23%)

01/10/18
ATLE
01/10/18
UPGRADE
ATLE
Overweight
Morgan Stanley upgraded to Overweight from Neutral at Atlantic Equities
01/10/18
ATLE
01/10/18
UPGRADE
Target $61
ATLE
Overweight
Morgan Stanley upgraded on tax reform benefits at Atlantic Equities
As previously reported, Atlantic Equities analyst John Heagerty upgraded Morgan Stanley (MS) to Overweight from Neutral, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Morgan Stanley shares to $61 from $48. The analyst also upgraded Wells Fargo (WFC) to Neutral from Underweight this morning, citing the same analysis of the potential benefits from tax reform.
01/10/18
01/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Neutral from Underweight at Atlantic Equities by analyst John Heagerty, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Wells Fargo shares to $64 from $55. The analyst also upgraded Morgan Stanley (MS) to Overweight this morning, citing the same analysis of the potential benefits from tax reform. 2. Deere upgraded to Outperform from Sector Perform at RBC Capital by analyst Seth Weber, who said he is positive on the company's leadership position in North American farm machinery which is stabilizing and exposure to the earth moving equipment category. The analyst is also constructive on Deere's recent Wirten Group acquisition. 3. Target (TGT) upgraded to Positive from Neutral at Susquehanna. 4. State Street (STT) and BNY Mellon (BK) upgraded to Buy from Neutral at Citi, with analyst Keith Horowitz saying he thinks the trust banks are the best way to play the digital transformation to the cloud and finds the current valuation as attractive. 5. RBS (RBS) upgraded to Overweight from Equal Weight at Morgan Stanley. Analyst Alvaro Serrano also downgraded Barclays (BCS) and Lloyds Banking (LYG). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/18
SOCG
01/09/18
DOWNGRADE
Target $59.5
SOCG
Hold
Morgan Stanley downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Andrew Lim downgraded Morgan Stanley to Hold saying the stock is now fairly priced following the recent rally. The analyst raised his price target for the shares to $59.50 from $55.
CS Credit Suisse
$18.36

-0.38 (-2.03%)

01/16/18
01/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Axalta Coating (AXTA) resumed with an Underperform at BofA/Merrill. 2. UBS (UBS) and Credit Suisse (CS) were initiated with an Underweight at Barclays. 3. Nutrien (NTR) initiated with a Neutral at Goldman Sachs. 4. Cambrex (CBM) initiated with an Outperform at William Blair. 5. Dicerna (DRNA) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
02/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he has become more optimistic on the immuno-oncology Opdivo + Yervoy combo in first-line lung cancer, which he notes is the largest cancer market. 2. Salesforce (CRM) upgraded to Buy from Hold at Jefferies with analyst John DiFucci saying recent field checks indicate continued strong enterprise traction as well improved commercial segment momentum, likely due to moderating Microsoft (MSFT) competition. 3. Credit Suisse (CS) upgraded to Buy from Hold at Societe Generale. 4. FMC Corporation (FMC) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying he sees near-term catalysts from the Ag market recovery and secular growth in lithium, which the company plans to spinoff. 5. Baidu (BIDU) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Grace Chen citing expectations for search sales reacceleration in 2018, the potential catalyst of the iQiyi IPO and the long-term potential contributions from AI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
SOCG
02/15/18
UPGRADE
SOCG
Buy
Credit Suisse upgraded to Buy from Hold at Societe Generale
01/16/18
LEHM
01/16/18
INITIATION
LEHM
Underweight
Credit Suisse initiated with an Underweight at Barclays
Barclays analyst Amit Goel started Credit Suisse with an Underweight rating and CHF 15.4 price target. The analyst thinks the company's new targets for 2019 and 2020 will not be achieved, along with some of the targets for 2018. He sees 16% downside potential from current share levels.
DB Deutsche Bank
$15.94

-0.46 (-2.80%)

11/20/17
KBWI
11/20/17
DOWNGRADE
KBWI
Underperform
Deutsche Bank downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst George Karamanos downgraded Deutsche Bank to Underperform.
02/19/18
BOFA
02/19/18
UPGRADE
BOFA
Neutral
Deutsche Bank upgraded to Neutral from Underperform at BofA/Merrill
02/14/18
02/14/18
DOWNGRADE
Target $48

Hold
Luxoft downgraded to Hold on 'elongated turnaround' at Pivotal Research
As previously reported, Pivotal Research analyst Lou Miscioscia downgraded Luxoft (LXFT) to Hold from Buy, as he now expects most of FY19 to be "a struggle." He had expected the company's two biggest customers - namely Deutsche Bank (DB) and UBS (UBS) - to be about flat for FY19, but now they are suggested to be down 20% and 5%, respectively, Miscioscia said. Noting also that the company cut its FY18 guidance along with its Q3 report, the analyst lowered his price target on Luxoft to $48 from $70.
11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
IBM IBM
$155.83

-0.72 (-0.46%)

01/23/18
01/23/18
NO CHANGE

IT Hardware industry view double-upgraded to Attractive at Morgan Stanley
Morgan Stanley analyst Katy Huberty upgraded her IT Hardware industry view by two notches, to Attractive from Cautious, stating that she now forecasts 6.6% average revenue growth in 2018. This level of growth would be an acceleration from the past few years and tops the consensus view of 5.9%, noted Huberty. She points to a survey of 100 CIOs that indicates faster planned IT budget growth than three months ago, expectations for faster gross margin expansion, and the benefits of U.S. tax reform to support her view. She favors stocks with enterprise exposure that don't price in a growth acceleration, naming HP Enterprise (HPE) and IBM (IBM) as her top picks. In the same note, Huberty raised her FY18 gross margin view for Apple (AAPL) and increased her price target on the iPhone maker's shares to $205 from $200. This morning, Huberty upgraded HP Enterprise to Overweight and upgraded NetApp (NTAP) and Teradata (TDC), both to Equal Weight from Underweight. She also downgraded HP Inc. (HPQ) to Equal Weight, as previously reported.
02/22/18
PIPR
02/22/18
INITIATION
Target $26
PIPR
Overweight
Pure Storage initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski started Pure Storage (PSTG) with an Overweight rating and $26 price target. The analyst believes the company will continue taking share from the legacy storage vendors, including Dell Technologies (DVMT), HP (HPQ) and IBM (IBM). Pure Storage's path to sustainable profitability is within reach, which should provide support for the valuation, Nowinski contends.
02/05/18
MSCO
02/05/18
UPGRADE
Target $180
MSCO
Overweight
Morgan Stanley double upgrades IT Services, moves Accenture to Overweight
Morgan Stanley analyst Brian Essex upgraded Accenture (ACN) to Overweight and raised his price target for the shares to $180 from $159. The analyst, following his firm's chief investment officer survey, believes the secular shift toward digital and cloud adoption is in the early stages. As such, Essex double upgraded his view on the IT Services industry to Attractive from Cautious. Vendors with strong positioning in consulting and system integration and next-gen applications should take market share, the analyst tells investors in a research note on the sector. Along with his upgrade of Accenture, the Essex highlights IBM (IBM) and Capgemini (CGEMY) as names poised to benefit relative to peers. He also raised his price target for Cognizant shares to $84 from $77.
01/19/18
SOCG
01/19/18
NO CHANGE
Target $149
SOCG
Sell
IBM price target lowered to $149 on 'lightweight' guidance at Societe Generale
Societe General analyst Richard Nguyen reduced IBM's FY18-19 earnings estimates by 3% and trimmed his price target to $149 from $152 given "lightweight" FY18 guidance and the steady downtrend in gross margins. Nguyen reiterated a Sell rating on IBM and believes any revenue growth could be driven more by FX tailwinds and the low comp base in 1H 2018 rather than a structural turnaround in its services businesses.
F Ford
$10.61

(0.00%)

02/01/18
NOMU
02/01/18
NO CHANGE
Target $11
NOMU
Neutral
Ford price target lowered to $11 from $12.80 at Nomura Instinet
Nomura Instinet analyst Anindya Das lowered his price target for Ford to $11 following a review of the company's Q4 results. The analyst now factors in a more adverse year-over-year headwind from commodity costs in 2018. He keeps a Neutral rating on Ford.
12/21/17
OPCO
12/21/17
NO CHANGE
Target $9
OPCO
Outperform
TeleNav extension with Ford should remove overhang, says Oppenheimer
Craig-Hallum analyst Steven Dyer notes that TeleNav (TNAV) announced preliminary Q2 results and amended its current agreement with Ford (F), which he believes is net/net positive for the P&L and should be a catalyst for shares. The analyst thinks the extension with Ford removes a major overhang on shares as it provides visibility for the next three years. Dyer reiterates an Outperform rating on TeleNav's shares, while lowering his price target on the stock to $9 from $12.
10/31/17
MSCO
10/31/17
NO CHANGE
Target $10
MSCO
Underweight
Ford bull case view raised despite 'significant headwinds' at Morgan Stanley
Morgan Stanley analyst Adam Jonas raised his 2017 EPS estimate for Ford to near the midpoint of the company's guidance following its Q3 report and slightly increased his price target on the stock to $10 from $9. While he keeps an Underweight rating on Ford, stating that the headwinds it faces are significant, he also sees the "scope for an equally significant response" and raised his bull case to $25 from $18 given a sum-of-the-parts analysis under which he values Ford's truck business, including the F-series and others, at nearly $20 per share, Ford Europe, S. America and Asia Pacific at "slightly less than zero" and "Ford Future" at $3B, or 74c per Ford share.
12/28/17
MSCO
12/28/17
NO CHANGE
MSCO
January to be busy for Autos and Shared Mobility names, says Morgan Stanley
Morgan Stanley analyst Adam Jonas previewed the January calendar for the Autos and Shared Mobility sector, noting that the Vegas CES takes place in the second week and the Detroit Auto Show occurs in the third week of next month. Judging from last year's shows and press releases in recent weeks, he expects "the vast majority" of prepared presentations will focus on autonomous driving, electric propulsion and new business models as companies seek to encourage recognition and valuation of "Auto 2.0 efforts" in the multiples of their stocks, he tells investors. Automakers covered by the firm include Fiat Chrysler (FCAU), Tesla (TSLA), General Motors (GM), Ferrari (RACE) and Ford (F). Auto suppliers covered include Magna (MGA), Goodyear Tire (GT), Adient (ADNT), Delphi Technologies (DLPH), Visteon (VC), BorgWarner (BWA), Aptiv (APTV) and Tenneco (TEN).
STT State Street
$106.15

-1.02 (-0.95%)

01/10/18
SBSH
01/10/18
UPGRADE
Target $115
SBSH
Buy
State Street upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded State Street (STT) to Buy and raised his price target for the shares to $115 from $105. The analyst thinks the trust banks are the best way to play the digital transformation to the cloud and finds the current valuation as attractive. Horowitz also upgraded BNY Mellon (BK) this morning citing a similar rationale.
10/24/17
RBCM
10/24/17
NO CHANGE
Target $104
RBCM
Sector Perform
State Street price target raised to $104 from $95 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on State Street to $104 following Q3 earnings. Cassidy notes the results featured higher operating revenues, better than expected noninterest income, and strong capital position with 11.3% Tier 1 common ratio. The analyst maintains a Sector Perform rating on State Street, citing in part the headwinds from stronger USD weakening the company's servicing revenues.
12/12/17
KBWI
12/12/17
UPGRADE
Target $110
KBWI
Outperform
State Street upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded State Street to Outperform and raised his price target for the shares to $110 from $94.
PMT PennyMac Mortgage
$16.67

-0.41 (-2.40%)

10/10/17
KBWI
10/10/17
DOWNGRADE
KBWI
Market Perform
PennyMac downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Bose George downgraded PennyMac Mortgage to Market Perform and lowered his price target for the shares to $18 from $19 ahead of the company's Q3 results.
FMCC Freddie Mac
$1.60

-0.05 (-3.03%)

SLM Sallie Mae
$10.91

-0.07 (-0.64%)

01/08/18
OPCO
01/08/18
INITIATION
OPCO
Perform
Navient initiated with a Perform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Navient (NAVI) with a Perform rating. Chittenden says the bulk of the company revenue still comes from its legacy loan book and private student loan portfolio, and both of those segments are under pressure. The analyst adds that 2019 could mark a key turning point, when Navient's non-compete agreement with Sallie Mae (SLM) expires, allowing it to originate private student loans again.
12/12/17
FBCO
12/12/17
NO CHANGE
FBCO
Outperform
Synchrony, Discover among biggest beneficiaries of tax reform, says Credit Suisse
Credit Suisse analyst Moshe Orenbuch views tax reform as highly beneficial to U.S. consumer finance companies as most companies are full U.S. tax payers and any increases in consumer confidence from more cash flow could lead to more consumer borrowing, driving faster revenue growth and improved credit quality. His favorites to benefit from tax reform are Synchrony (SYF), Discover (DFS), OneMain (OMF), CIT Group (CIT), Santander Consumer (SC), Sallie Mae (SLM), and Air Lease (AL).
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Sallie Mae with an Outperform rating and a price target of $17, citing a "secular mix shift away from Federal funding of educational tuition and toward private lenders" where the company has a leading market share. The analyst says Sallie Mae will continue to benefit from better efficiency ratio, estimating mid-30s % versus "40% range" currently.
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ben Chittenden started Sallie Mae with an Outperform rating and $17 price target.

TODAY'S FREE FLY STORIES

BECN

Beacon Roofing

$39.77

-0.19 (-0.48%)

14:21
07/16/18
07/16
14:21
07/16/18
14:21
Hot Stocks
Beacon Roofing acquires Atlas Supply »

Beacon Roofing Supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$320.52

-1.28 (-0.40%)

, BA

Boeing

$355.82

5.01 (1.43%)

14:17
07/16/18
07/16
14:17
07/16/18
14:17
Periodicals
Talent scarce for defense firms despite jump in military spending, NYT says »

According to the New York…

NOC

Northrop Grumman

$320.52

-1.28 (-0.40%)

BA

Boeing

$355.82

5.01 (1.43%)

LMT

Lockheed Martin

$318.09

-0.35 (-0.11%)

GD

General Dynamics

$191.29

-1.5 (-0.78%)

RTN

Raytheon

$199.63

-0.09 (-0.05%)

UTX

United Technologies

$129.14

-0.4 (-0.31%)

BAESY

BAE Systems

$0.00

(0.00%)

GOOG

Alphabet

$1,186.00

-2.81 (-0.24%)

BABA

Alibaba

$190.58

0.55 (0.29%)

FB

Facebook

$208.14

0.81 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 10

    Sep

  • 18

    Sep

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/16/18
07/16
14:17
07/16/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/16/18
07/16
14:16
07/16/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBG

Hub Group

$49.00

-1.95 (-3.83%)

14:10
07/16/18
07/16
14:10
07/16/18
14:10
Options
Unusually large option print in Hub Group as shares slump »

Unusually large option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:10
07/16/18
07/16
14:10
07/16/18
14:10
General news
Fed's Kashkari worries about the flattening yield curve »

Fed's Kashkari…

JBHT

J.B. Hunt

$120.99

-0.78 (-0.64%)

14:08
07/16/18
07/16
14:08
07/16/18
14:08
Recommendations
J.B. Hunt analyst commentary  »

Loop says J.B. Hunt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

SYRS

Syros Pharmaceuticals

$12.35

(0.00%)

14:08
07/16/18
07/16
14:08
07/16/18
14:08
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EQGP

EQT GP

$24.87

-0.25 (-1.00%)

, EQM

EQT Midstream Partners

$54.90

0.49 (0.90%)

14:02
07/16/18
07/16
14:02
07/16/18
14:02
Conference/Events
Rice Midstream to host special shareholder meeting »

Special Shareholder…

EQGP

EQT GP

$24.87

-0.25 (-1.00%)

EQM

EQT Midstream Partners

$54.90

0.49 (0.90%)

RMP

Rice Midstream

$18.16

0.16 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

CRSP

Crispr Therapeutics

$59.61

-6.13 (-9.32%)

14:01
07/16/18
07/16
14:01
07/16/18
14:01
Periodicals
Crispr Therapeutics tells CNBC does not use methods described in paper »

Crispr Therapeutics told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$37.79

-0.22 (-0.58%)

14:00
07/16/18
07/16
14:00
07/16/18
14:00
Options
Bullish option play opened in Masco ahead of earnings »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CRSP

Crispr Therapeutics

$59.09

-6.65 (-10.12%)

13:55
07/16/18
07/16
13:55
07/16/18
13:55
Options
Crispr Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
07/16/18
07/16
13:50
07/16/18
13:50
General news
U.S. equities are up from earlier lows »

U.S. equities are up from…

ECA

Encana

$12.84

-0.4 (-3.02%)

13:45
07/16/18
07/16
13:45
07/16/18
13:45
Options
Encana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Oct

ADS

Alliance Data

$220.17

-23.32 (-9.58%)

13:44
07/16/18
07/16
13:44
07/16/18
13:44
Technical Analysis
Technical Take: Alliance Data comes off the lows of the day »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

CRM

Salesforce

$147.50

-0.18 (-0.12%)

13:39
07/16/18
07/16
13:39
07/16/18
13:39
Hot Stocks
Salesforce announces definitive agreement to acquire Datorama »

Salesforce has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 16

    Aug

YELP

Yelp

$40.33

0.54 (1.36%)

13:35
07/16/18
07/16
13:35
07/16/18
13:35
Options
Yelp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBIX

Leading Brands

$1.62

-0.06 (-3.57%)

13:32
07/16/18
07/16
13:32
07/16/18
13:32
Hot Stocks
Leading Brands announces resolution of temporary non-compliance with Nasdaq rule »

Leading Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$22.84

0.2 (0.88%)

13:25
07/16/18
07/16
13:25
07/16/18
13:25
Options
STMicroelectronics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

13:25
07/16/18
07/16
13:25
07/16/18
13:25
Conference/Events
Stephens agricultural analyst to hold an analyst/industry conference call »

Agriculture, Chemicals,…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

, NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

13:23
07/16/18
07/16
13:23
07/16/18
13:23
Periodicals
Editas tells CNBC 'not specifically concerned about' Crisper study »

Editas Medicine (EDIT)…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$68.30

-0.33 (-0.48%)

13:19
07/16/18
07/16
13:19
07/16/18
13:19
Periodicals
CVS apologizes after store managers call police on black customer, AP says »

CVS Health is apologizing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/16/18
07/16
13:17
07/16/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/16/18
07/16
13:16
07/16/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGI

Pattern Energy

$17.84

0.75 (4.39%)

13:10
07/16/18
07/16
13:10
07/16/18
13:10
Options
Change of sentiment in Pattern Energy »

Change of sentiment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.